Chronic spontaneous urticaria Trials in Birmingham, United States
Conditions / Chronic spontaneous urticaria / Birmingham, United States
Chronic spontaneous urticaria is a medical condition with active clinical research programs worldwide.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05513001 | An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05030311 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines | COMPLETED | PHASE3 |
| NCT06077773 | Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria | TERMINATED | PHASE2 |
| NCT06445023 | A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03580356 | A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. | COMPLETED | PHASE3 |
| NCT02477332 | Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU | COMPLETED | PHASE2 |
| NCT04210843 | Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab | TERMINATED | PHASE3 |
| NCT05032157 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines | COMPLETED | PHASE3 |
| NCT04833855 | Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria | COMPLETED | PHASE2 |
| NCT05528861 | A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria | TERMINATED | PHASE2 |